Your browser doesn't support javascript.
loading
Tyrosine kinase Eph receptor A6 sensitizes glioma-initiating cells towards bone morphogenetic protein-induced apoptosis.
Raja, Erna; Morikawa, Masato; Nishida, Jun; Tanabe, Ryo; Takahashi, Kei; Seeherman, Howard J; Saito, Nobuhito; Todo, Tomoki; Miyazono, Kohei.
Affiliation
  • Raja E; Department of Molecular Pathology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
  • Morikawa M; Department of Molecular Pathology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
  • Nishida J; Department of Molecular Pathology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
  • Tanabe R; Department of Molecular Pathology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
  • Takahashi K; Department of Molecular Pathology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
  • Seeherman HJ; Bioventus LLC, Boston, MA, USA.
  • Saito N; Department of Neurosurgery, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
  • Todo T; Division of Innovative Cancer Therapy, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
  • Miyazono K; Department of Molecular Pathology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Cancer Sci ; 110(11): 3486-3496, 2019 Nov.
Article in En | MEDLINE | ID: mdl-31483918
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Brain Neoplasms / Apoptosis / Glioblastoma / Activin Receptors, Type I / Receptor, EphA6 / Bone Morphogenetic Protein 2 Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Cancer Sci Year: 2019 Document type: Article Affiliation country: Japan Country of publication: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Brain Neoplasms / Apoptosis / Glioblastoma / Activin Receptors, Type I / Receptor, EphA6 / Bone Morphogenetic Protein 2 Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Cancer Sci Year: 2019 Document type: Article Affiliation country: Japan Country of publication: United kingdom